文献速递肝胆胰外科

基于门静脉流域与病变胆管树流域肝切除治疗肝胆管结石的疗效与安全性比较

[Efficacy and safety for hepatolithiasis patients treated with hepatectomy based on portal territory versus diseased biliary tree territory: an inverse probability of treatment weighting comparative study].
PubMed 文献 · Zhonghua Wai Ke Za Zhi · 2026-01-01

本研究为双中心回顾性队列研究,纳入365例肝胆管结石病患者,采用逆概率加权(IPTW)比较病变胆管树流域切除与门静脉流域切除的疗效与安全性。IPTW后病变胆管树流域组总体并发症率和腹水率均显著低于门静脉流域组,5年无复发间隔率两组差异无统计学意义。

要点

  • 病变胆管树流域肝切除总体并发症率49.7%,低于门静脉流域组63.7%。
  • 病变胆管树流域组腹水发生率9.4%,低于门静脉流域组18.6%。
  • 两组5年无复发间隔率分别为79.9%与73.9%,差异无统计学意义。

核心结论

  • 病变胆管树流域肝切除的总体并发症发生率和腹水发生率低于门静脉流域肝切除,两者有效性相似。

研究设计与样本

  • 双中心回顾性队列研究,纳入2014年1月至2020年1月365例肝胆管结石病患者。
  • 按手术方式分为病变胆管树流域切除组262例和门静脉流域切除组103例。
  • 采用逆概率加权(IPTW)平衡基线特征,IPTW后病变胆管树流域组318例、门静脉流域组361例。

主要发现

  • IPTW后病变胆管树流域组总体并发症发生率为49.7%(158/318),门静脉流域组为63.7%(230/361),χ2=13.016,P<0.01。
  • IPTW后病变胆管树流域组腹水发生率为9.4%(30/318),门静脉流域组为18.6%(67/361),χ2=10.765,P=0.001。
  • 两组5年无复发间隔率分别为79.9%与73.9%,差异无统计学意义(P=0.126)。

临床怎么用

  • 在治疗肝胆管结石病时,可优先考虑病变胆管树流域肝切除以降低总体并发症和腹水风险。
  • 两种术式的远期无复发间隔率相似,术式选择需结合结石分布与胆管受累范围个体化决定。

局限性

  • 本研究为回顾性队列研究,虽采用IPTW模拟随机试验,但仍可能存在未测量混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To compare the efficacy and safety of hepatectomy based on portal vein territory versus hepatectomy based on diseased biliary tree territory in treating hepatolithiasis. Methods: This is a retrospective cohort study,and clinical data from consecutive 365 hepatolithiasis patients from two hospitals between January 2014 and January 2020 were collected. The cohort included 123 males and 242 females,with an age of (54.0±11.9) years (range: 13 to 83 years). Participants were grouped according to surgical approach. The regional hepatectomy group based on the territories of affected bile ducts comprised 262 cases (88 males,174 females),with an age of (53.9±12.0) years. The hepatectomy group based on the portal vein territories comprised 103 cases (35 males,68 females), with an age of (54.4±11.7) years. Observation indicators: (1) Recurrence-free interval;(2) Complication rates (intraoperative,postoperative,and long-term). Inverse probability of treatment weighting (IPTW) was employed to simulate a randomized trial by weighting observations with the inverse of the treatment probability,thereby eliminating confounding bias and balancing baseline characteristics between patients undergoing lesion bile duct tree basin resection and those undergoing portal vein basin resection. The safety and efficacy outcomes between the two groups were compared using the χ2 test, the Mann-Whitney U test, as well as Kaplan-Meier curves with the Log-rank test. Results: After IPTW,318 patients were included in the diseased biliary tree territory group and 361 patients were included in the portal vein territory group. The overall morbidity rate and ascites rate in the diseased biliary tree territory group were both significantly lower than those in the portal vein territory group (after IPTW: 49.7% (158/318) vs. 63.7% (230/361), χ2=13.016, P<0.01; 9.4% (30/318) vs. 18.6% (67/361), χ2=10.765, P=0.001,respectively). The 5-year recurrence-free interval rates in the resection group of the diseased bile duct tree basin and the resection group of the portal vein basin were 79.9% and 73.9%, respectively, with no statistically significant difference (P=0.126). Conclusion: The total complication rate and ascites incidence following hepatectomy targeting the diseased biliary drainage territory are somewhat lower than those after portal vein territory hepatectomy,while both approaches demonstrated comparable efficacy. 目的: 比较病变胆管树流域切除术和门静脉流域切除术治疗肝胆管结石病的安全性和有效性。 方法: 本研究为双中心回顾性队列研究。收集2014年1月至2020年1月我国两家医学中心收治的365例肝胆管结石病患者的临床资料。男性123例,女性242例;年龄(54.0±11.9)岁(范围:13~83岁)。根据手术方式进行分组,病变胆管树流域切除组262例,男性88例,女性174例,年龄(53.9±12.0)岁;门静脉流域切除组103例,男性35例,女性68例,年龄(54.4±11.7)岁。观察指标:(1)无复发间隔;(2)术中、术后及远期并发症情况。采用逆概率加权(IPTW)匹配,通过治疗概率的倒数加权模拟随机试验以消除混杂偏倚,平衡病变胆管树流域切除组和门静脉流域切除组患者之间的基线特征。通过χ2 检验、Mann-Whitney U检验,以及采用Kaplan-Meier曲线和Log-rank检验比较病变胆管树流域切除组和门静脉流域切除组的安全性和有效性结局。 结果: 经IPTW匹配后,病变胆管树流域切除组318例,门静脉流域切除组361例。匹配后病变胆管树流域切除组患者的总体并发症发生率和腹水发生率均低于门静脉流域切除组[49.7%(158/318)比63.7%(230/361),χ2=13.016,P<0.01;9.4%(30/318)比18.6%(67/361),χ2=10.765,P=0.001];病变胆管树流域切除组与门静脉流域切除组的5年无复发间隔率分别为79.9%与73.9%,差异无统计学意义(P=0.126)。 结论: 病变胆管树流域肝切除总体并发症发生率、腹水发生率低于门静脉流域肝切除,而二者有效性相似。.

来源:Zhonghua Wai Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Liu ZP, Luo YL, Yang YS, et al. [Efficacy and safety for hepatolithiasis patients treated with hepatectomy based on portal territory versus diseased biliary tree territory: an inverse probability of treatment weighting comparative study]. Zhonghua Wai Ke Za Zhi. 2026. PMID: 41771527. doi:10.3760/cma.j.cn112139-20250912-00440

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。